• Embed Doc
  • Copy Link
  • Readcast
  • Collections
  • CommentGo Back
Download
 
 
FORWARD INQUIRIES TO:
SAFC PharmaDavid FeldkerVice President, SAFC+1-314-289-8467 
MEDIA INQUIRIES: IMPRESS PUBLIC RELATIONS
Richard Kerns+ 44-(0)161-728-5880richard@impress-pr.com Mark Button+1-503-616-3817mark@impress-pr.com 
SAFC PHARMA
 ® 
ANNOUNCES COMPLETION OF $12M CONTRACTMANUFACTURING FACILITY EXPANSION IN CARLSBAD, CALIF.
 Addition Enhances Capabilities and Capacity Bolsters Biologics and Viral Manufacturing; Reinforces Support for Secure, Successful Customer Launches
ST. LOUIS, MO., October 13, 2009 –
SAFC Pharma
 ® 
, a business segment of SAFC
 ® 
, amember of the Sigma-Aldrich
 ® 
Group
(NASDAQ: SIAL)
, today announced the completion of anaddition to its Carlsbad, Calif., facility that expands the Company’s contract manufacturingservices for its late phase and commercial clients. The $12 million project includes the additionof two fully segregated state-of-the-art viral product manufacturing suites, built to employ thelatest in disposable bioreactor technologies, expanding SAFC Pharma’s biologics, viral vaccinesand gene therapy manufacturing to commercial-scale quantities.SAFC Pharma’s Carlsbad site specializes in the process development and manufacturing ofviral vaccines and viral therapeutics, including a full menu of support services, from preclinicalprocess and analytical development to final fill/finish and commercial bulk drug supplies. Thenew expansion, designed for multi-lot campaigns, includes dedicated cell expansion, bioreactorproduction, purification and cleanroom suites. Adding 8,000 sq. ft. of manufacturing space to theexisting 44,000 sq. ft. site, the addition enables both 100-liter batch production in stirred tank
(more)
 
 
 
Page 2 
bioreactors and 1,000-liter batch manufacturing in disposable bioreactors, and is BiosafetyLevel 2 compliant, allowing manipulation of human pathogens. Designed from the outset as acontainment facility, the expansion space allows clients to secure a dedicated suite ofcleanrooms for larger scale manufacturing.“We are delighted to announce this expansion of our capabilities at our Carlsbad facility,particularly when the economic environment has been so challenging,” commented DavidFeldker, Vice President SAFC Pharma. “We expect to see a great deal of value in the biologicsand viral manufacturing marketplace in the next three to five years generated by two maincustomer types - those with late clinical phase opportunities but without any in-housemanufacturing capability and those with late clinical phase opportunities that have somemanufacturing capabilities but may be seeking an additional ‘safety net’ or wish to avoidadditional capital expansion until their technology and drug has proven itself. By adding andextending our capabilities at Carlsbad, we are providing customers with an attractive, clearpathway that adds value and supports secure, successful product launches.”“The expansion at our Carlsbad campus underlines SAFC’s strategy to continue to invest inbuilding world class capabilities that serve and enhance our leadership in important emergingnew technologies such as niche biologics production and viral manufacturing - areas where wesee great potential and traction,” added SAFC President Gilles Cottier. “Our investment in largecapacity manufacturing, our financial stability, experience and quality systems differentiates usin the market and enhances our abilities to securely support our customers all the way tosuccessful product launch.”Facility validation studies are currently underway, with an expected start of cGMPmanufacturing operations by the end of December 2009. The site added numerous utilitysupport systems to allow for continuous operation and will now utilize its new Water ForInjection (WFI) system. The Company has enjoyed a close relationship with a number of clientsdeveloping an exciting array of cancer therapeutics, gene therapies and mammalian and insectcell-based viral vaccines.
(more)
of 00

Leave a Comment

You must be to leave a comment.
Submit
Characters: ...
You must be to leave a comment.
Submit
Characters: ...